Applicant, as named in the Orange Book
Owp Pharms
Next listed expiry: Subvenite on 29 May 2040. 1 products with live protection, 0 without.
Products with listed protection
| Drug | Earliest generic entry |
|---|---|
| Subvenite NDA 218879 lamotrigine | 29 May 2040 patent |
Recent events
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.